India Vaccine Approval
- All
- News
- Videos
-
'Caution Not Anti-Science': Siddaramaiah On Covid Vaccine-Sudden Death Claim
Karnataka Chief Minister Siddaramaiah has responded to Biocon Ltd Executive Chairperson Kiran Mazumdar-Shaw's suggestion that he acknowledge the science behind vaccine development, rather than engage in retrospective blame.
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
Covovax Booster Dose To Be Available On CoWIN, Cost Rs 225: Report
Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
India's Intranasal Covid Vaccine Is Here. Can Be Availed On COWIN Platform
Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above and is likely to be introduced on the Co-WIN platform Friday evening, official sources said.
-
Nasal Vaccine Available From Today. Where You Can Get It
The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.
-
Hyderabad-Based Biological E Gets Approval For Pneumococcal Conjugate Vaccine
Hyderabad-based pharmaceutical and vaccine manufacturer Biological E Limited (BE), on Friday announced that its 14-valent paediatric Pneumococcal Conjugate Vaccine has received approval for manufacture and commercialisation in India.
-
Government Rubbishes Reports On Approval For Covaxin Due To Political Pressure
The Union Health Ministry today termed as "misleading" and "fallacious" media reports which claimed that regulatory approval for COVID-19 vaccine Covaxin was rushed due to political pressure.
-
Nasal Vaccines Could Be Beneficial In Controlling Covid: WHO
Nasal Covid-19 vaccines could help to bring the Covid-19 pandemic under control, the World Health Organization said Wednesday after homegrown products were approved in India and China.
-
New Nasal Vaccine Against Covid-19: Your 5-Point Guide
A nasal vaccine against Covid-19, iNCOVACC, developed by Bharat Biotech, has been approved by India's Central Drugs Standard Control Organisation. This is India's first intra-nasal vaccine against Covid-19
-
'Bivalent' Booster For Omicron, Original Covid Strain Approved By UK
The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
-
Serum Institute's Covid Vaccine Covovax Cleared For 7-11 Age Group
The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute's COVID-19 vaccine Covovax for restricted emergency use in children aged 7 to 11 years subject to certain conditions, official sources said.
-
Immunisation Panel Approves Covovax Vaccine For 12-17 Age Group: Report
National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
-
'Caution Not Anti-Science': Siddaramaiah On Covid Vaccine-Sudden Death Claim
Karnataka Chief Minister Siddaramaiah has responded to Biocon Ltd Executive Chairperson Kiran Mazumdar-Shaw's suggestion that he acknowledge the science behind vaccine development, rather than engage in retrospective blame.
-
Top Medical Body Slams Study On Covaxin Safety, Side-Effects, Wants Apology
The Indian Council of Medical Research, or ICMR, has distanced itself from a follow-up study by two Banaras Hindu University professors that said nearly a third of 926 individuals who got the India-made Covaxin shot reported serious side-effects.
-
Covovax Booster Dose To Be Available On CoWIN, Cost Rs 225: Report
Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
India's Intranasal Covid Vaccine Is Here. Can Be Availed On COWIN Platform
Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above and is likely to be introduced on the Co-WIN platform Friday evening, official sources said.
-
Nasal Vaccine Available From Today. Where You Can Get It
The government today approved the inclusion of an intranasal Covid vaccine in the vaccination programme as a booster dose for adults. The inclusion comes amid a surge in cases in China and some other countries.
-
Hyderabad-Based Biological E Gets Approval For Pneumococcal Conjugate Vaccine
Hyderabad-based pharmaceutical and vaccine manufacturer Biological E Limited (BE), on Friday announced that its 14-valent paediatric Pneumococcal Conjugate Vaccine has received approval for manufacture and commercialisation in India.
-
Government Rubbishes Reports On Approval For Covaxin Due To Political Pressure
The Union Health Ministry today termed as "misleading" and "fallacious" media reports which claimed that regulatory approval for COVID-19 vaccine Covaxin was rushed due to political pressure.
-
Nasal Vaccines Could Be Beneficial In Controlling Covid: WHO
Nasal Covid-19 vaccines could help to bring the Covid-19 pandemic under control, the World Health Organization said Wednesday after homegrown products were approved in India and China.
-
New Nasal Vaccine Against Covid-19: Your 5-Point Guide
A nasal vaccine against Covid-19, iNCOVACC, developed by Bharat Biotech, has been approved by India's Central Drugs Standard Control Organisation. This is India's first intra-nasal vaccine against Covid-19
-
'Bivalent' Booster For Omicron, Original Covid Strain Approved By UK
The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
-
Serum Institute's Covid Vaccine Covovax Cleared For 7-11 Age Group
The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute's COVID-19 vaccine Covovax for restricted emergency use in children aged 7 to 11 years subject to certain conditions, official sources said.
-
Immunisation Panel Approves Covovax Vaccine For 12-17 Age Group: Report
National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
